TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SU9T436

Market Closed - Boerse Frankfurt Warrants 15:48:37 2024-05-10 EDT
3.59 EUR 0.00% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
Current month-4.00%
1 month-8.63%
Date Price Change Volume
24-05-10 3.6 +0.28% 0
24-05-09 3.59 -2.18% 0
24-05-08 3.67 +1.10% 0
24-05-07 3.63 -6.20% 0
24-05-06 3.87 +0.52% 0

Real-time Boerse Frankfurt Warrants

Last update May 10, 2024 at 03:48 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SU9T43
ISINDE000SU9T436
Date issued 2024-02-23
Strike 168.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.85
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.5
Lowest since issue 3.32

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW